Plexus Holdings PLC (AIM:POS) announced that it has been shortlisted in the 'Environmental Sustainability Innovation' and 'Significant Contribution to the Industry' categories of the Offshore Network's OWI Global Awards 2022.
Commenting on the nominations, in a statement, Plexus' CEO Ben Van Bilderbeek said: "We are absolutely delighted to be included in these two categories and thank the OWI for the nominations. Our proprietary wellhead technology has been supporting the oil and gas industry for many years, particularly with regards to our 'through the BOP' and leak-proof 'HG' metal-to-metal sealing technology, which can help reduce methane gas emissions, over the lifetime of a well, thereby helping operators meet their ESG goals."
Arecor Therapeutics PLC (AIM:AREC) has announced positive results from the Phase I clinical trial of its ultra-rapid acting, ultra-concentrated insulin product candidate, AT278, at the European Association for the Study of Diabetes (EASD) Annual Meeting.
AT278 is designed to significantly accelerate insulin absorption post-injection to enable more effective and convenient management of blood glucose levels in people with high daily insulin requirements.
Ondine Biomedical Inc (AIM:OBI) has noted new research that shows photodisinfection successfully eradicates pathogens associated with replacement joint infections.
The company pointed out that a research team in Zurich, Switzerland has presented results from an in vitro study showing that photodisinfection achieved more than 99.99% eradication (4-7 log10 kill) of the key pathogens in biofilms associated with implantable joint infections, with no reported re-growth.
Gaming Realms PLC (AIM:GMR, OTCQX:PSDMF) reported a 66% increase in interim profits and said it expects full-year trading to be in line with market expectations.
The developer and licensor of mobile-focused games posted a pretax profit of £1.3mln for the six months to June 30 with a 10% jump in sales to £8.5mln, driven by growth in its content licensing business
Faron Pharmaceuticals Limited (AIM:FARN, OTC:FPHAF) said data from its early phase clinical trial showed patients taking its cancer drug enjoyed a significantly higher survival rate than those who didn’t receive it.
Bexmarilimab was used on multiple different tumour types to assess both its safety and efficacy in the MATINS study designed to assess different dosing regimens.
Chaarat Gold Holdings Ltd (AIM:CGH) noted transactions to the stock exchange in which chairman Martin Andersson, via the Labro Investments Limited vehicle, saw his interest in the company. Labro acquired around 295,000 additional Chaarat shares, taking its interest in the company to 307.81mln shares or 44.63% of the company.
Xpediator PLC (AIM:XPD) gave notice that its interim results, for the six months ended June 30, will be released on Monday 26 September.
ATOME Energy PLC (AIM:ATOM) gave notice that its interim results, for the six months ended June 30, will be released on Monday 26 September.
Pantheon Resources PLC (AIM:PANR, OTC:PTHRF) noted that three directors have sold shares in the company that were issued as following the exercise of company share options. Chief executive Jay Cheatham sold 1.3mln shares, Justin Hondris director for finance and corporate development sold 2mln shares, and Robert Rosenthal technical director sold 900,000 shares. The transactions had an averaged price of 123.4p.
In a statement, Pantheon chair Phillip Gobe told investors that the shares sales precede an extended flow test of a key well in Alaska, due to take place next month, and therefore the company could see a prolonged 'closed period' for director dealing.
"Today's announcement represents only the second occasion since the Company's IPO in 2006 that any director has sold shares in the company,” Gobe said.
Tlou Energy Ltd (AIM:TLOU, ASX:TOU, BSE:TLOU) managing director Tony Gilby said the company hit several significant targets over the past year. “Signing the PPA and being the first Independent Power Producer (IPP) in Botswana to do so was a major accomplishment. “Starting work on the transmission line grid connection was another notable success and we are grateful for the continued support of BPOPF. Losses for the year to end-June 2022 were A$4.3mln (A$2.5mln).
UK self-invested personal pension (SIPP) provider Curtis Banks Group PLC (AIM:CBP) has announced the payment schedule of its 2.5p interim dividend declaration. Ex-dividend date will be October 6 with an October 7 record date, while payment is pegged for November 11